21 results
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals Inc
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
Exhibit 14.1
DAY ONE BIOPHARMACEUTICALS, INC.
CODE OF BUSINESS CONDUCT AND ETHICS
THIS POLICY WAS APPROVED BY THE BOARD ON DECEMBER 7, 2023 … with integrity – both in terms of how we treat each other, and in terms of how we run our business. This Code of Business Conduct and Ethics (“Code”) is intended
8-K
DAWN
Day One Biopharmaceuticals Inc
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
to Section 13(a) of the Exchange Act. ☐
Item 5.05
Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics … of Business Conduct and Ethics (as amended, the “Code”) upon the recommendation of the Audit Committee of the Board. The Code was approved and adopted
PRE 14A
fs4v1ktwl04l npdrkp5
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
8au 3ciagpv9ll
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
djprfvm1 wd
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
DEF 14A
v7u7ki14332p4xm58gf
28 Apr 22
Definitive proxy
4:44pm
10-K
b9ku4
7 Mar 22
Annual report
7:36am
10-Q
1lcadsf
10 Aug 21
Quarterly report
5:26pm
424B4
4wzefn 5jbquime5w
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
di3osakn2
24 May 21
IPO registration (amended)
6:16am
S-1
EX-10.7
el7gum drwlrqtzf7bda
4 May 21
IPO registration
4:12pm
S-1
9wb5l2
4 May 21
IPO registration
4:12pm